Combining Taiwan’s biomedical research capabilities, international clinical development experiences and competitiveness in commercialization of state of the art technologies, Medigen has built up a portfolio of patent protected projects which will be transformed into products approved by the regulatory bodies of various countries. Medigen aims to become one of the leading biotech companies in Asia and then a multinational biomedical group through expansion into new businesses and merger and acquisition. Based on the idea of guarding the life and health of human beings, Medigen puts into practice its motto of “Innovations for a better life”.